"We believe this new clinical trial will be a cornerstone of our future plans to develop Cotara for the treatment of this deadly form of cancer," said Steven W. King, president and CEO of Peregrine. "We are moving this program forward in India because of the high level of experience of the participating neurosurgeons with CED delivery, the state-of-the-art facilities of the medical centers involved and the fact that the contract research organization overseeing the trial is highly experienced in successfully running similar glioblastoma trials with many of the investigators who will be involved with our study."The study will be conducted in 7 clinical centers, and may enroll up to 40 patients with glioblastoma who have experienced their first relapse. Enrollment is expected to be completed by the end of 2007.
Source: Peregrine
We have a 3 year old child with first relapse of glioblastoma multiforme.Would like to know if he could be included in the clinical trial for Cotara
Posted by: Dr.Nalini Bhaskaranand | January 11, 2008 5:00 AM | Permalink to Comment